Advertisement

Topics

InterCure Ltd. Company Profile

00:09 EST 16th November 2018 | BioPortfolio

InterCure Ltd. (Tel-Aviv Stock Exchange: INCR) is disrupting the $42 billion hypertension industry with the world's first FDA-cleared, OTC blood pressure treatment device, RESPeRATE(R) (http://www.resperate.com). In a market where seven out of 10 hypertensives are NOT controlled despite the availability of more than 100 blood pressure medications, RESPeRATE provides an effective non-drug therapy with no side effects.


News Articles [4 Associated News Articles listed on BioPortfolio]

InterCure buys medical cannabis co Canndoc

InterCure's share price has risen 120% this week and 520% since June.

Israeli cannabis co InterCure raises $12m

Former prime minister Ehud Barak, chairman of InterCure: I have never encountered such great interest and such a big dream.

Medical cannabis co InterCure names Ehud Barak chairman

Barak will lead global strategy for InterCure, which is changing its name to Canndoc Pharma after buying Israeli medical cannabis pioneer Canndoc.

Intercure becomes tenth TASE medical cannabis co

The Israeli company's share price skyrocketed 141% following the announcement that it was adopting medical cannabis activities.

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [2 Associated Companies listed on BioPortfolio]

Intercure, Inc.

InterCure, a medical device company has developed and patented a technology platform for respiratory-based treatment of cardiovascular and pulmonary diseases. The Company has incorporated its "Interac...

InterCure Ltd.

InterCure Ltd. (Tel-Aviv Stock Exchange: INCR) is disrupting the $42 billion hypertension industry with the world's first FDA-cleared, OTC blood pressure treatment device, RESPeRATE(R) (http://www...

More Information about "InterCure Ltd." on BioPortfolio

We have published hundreds of InterCure Ltd. news stories on BioPortfolio along with dozens of InterCure Ltd. Clinical Trials and PubMed Articles about InterCure Ltd. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of InterCure Ltd. Companies in our database. You can also find out about relevant InterCure Ltd. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Adempas (riociguat)
The United States Food and Drug Administration (FDA) has approved on October 8th 2013 Adempas® (riociguat) tablets for: (i) the treatment of adults with persistent/recurrent chronic thromboembolic pulmonary hypertension (CTEPH) (WHO* Group 4) after ...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...


Corporate Database Quicklinks



Searches Linking to this Company Record